InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Pepose Jay, Director. Insider active across 1 company, notably Ocuphire Pharma, Inc.. Cumulatively, 10 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €77k. Activity tracked since 13 September 2021. The latest transaction was disclosed on 11 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pepose Jay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
41,143 shares0Common StockSEC:0000905148-24-001713:0
32,000 shares0Common StockSEC:0000905148-24-001166:0
14,964 sharesCommon StockSEC:0001140361-24-000498:0
35,000 shares0Common StockSEC:0001140361-23-052988:0
10,976 shares0Common StockSEC:0001140361-23-029022:0
468 sharesCommon StockSEC:0001140361-23-019674:0
13,013 sharesCommon StockSEC:0001140361-23-001516:0
9,900 sharesCommon StockSEC:0001140361-22-025282:0
8,250 shares@ US$3.6534.4% of flowCommon StockSEC:0001140361-21-041622:0
Canonical exit: 13 Mar 2022 (T+90)
12,631 shares@ US$4.7565.6% of flowCommon StockSEC:0001140361-21-031308:0
Canonical exit: 12 Dec 2021 (T+90)
10 of 10 declarations
About Pepose Jay
Pepose Jay is Administrateur at Ocuphire Pharma, Inc. (XNAS). He has 10 filings in total, and across the 10 most recent filings we hold, the period runs from 2021-09-15 to 2024-06-13, with EUR 77414 of buys and EUR 0 of sells; the modal transaction nature is Attribution.
